This observational study investigated the effects of hexarelin, a growth hormone (GH) releasing peptide, on GH secretion in patients with homozygous beta-thalassemia, a genetic disorder often associated with growth retardation due to impaired GH secretion. The results showed that hexarelin effectively stimulated GH release, producing GH peaks comparable to those
